Learn about GAMUNEX-C, a CIDP, and PIDD treatment option, its efficacy, safety information and patient support. |GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified)
People living with CIDP treated with GAMUNEX-C share their stories. Start watching How it’s given Learn how GAMUNEX-C is administered and what you can expect during an infusion. Watch video Tools & resources Explore videos and other resources that may help you before, during, and after ...
GAMUNEX®-C Immune Globulin Injection (Human) 10% Caprylate/Chromatography Purified HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GAMUNEX®-C safely and effectively. See full prescribing information for GAMUNEX-C. GAMUNEX-C, [Immune Globulin ...
1. Indications and Usage for Gamunex-C GAMUNEX-C is an immune globulin injection (human) 10% liquid that is indicated for the treatment of: 1.1 Primary Humoral Immunodeficiency (PI) GAMUNEX-C is indicated for treatment of primary humoral immunodeficiency in patients 2 years of age and older. ...
摘要:FDA批准Talecris Biotherapeutics公司10%辛酸盐/色谱分离纯化人免疫球蛋白静脉注射液[(Immune Globulin Intravenous(Human),Gamunex)用于治疗慢性炎症性脱髓鞘性多发性神经病(CIDP).CIDP是退行性神经系统疾病,可造成肌肉无力和乏力,导致运动技能严重损伤。
Gamunex)用于治疗慢性炎症性脱 髓鞘性多发性神经病(CIDP o CIDP是退行性神经系统疾病, 可造成肌肉无力和乏力,导致运动技能严重损伤。 本品适用于替代治疗原发性激素免疫缺乏疾病(PI】 、免 疫调节治疗特发性血小板减少性紫癜(ITP ) 和 C ID P ,其是 ...
FDA批准Talecris Biotherapeutics公司10%辛酸盐/色谱分离纯化人免疫球蛋白静脉注射液[(Immune Globulin Intravenous(Human),Gamunex)用于治疗慢性炎症性脱髓鞘性多发性神经病(CIDP).CIDP是退行性神经系统疾病,可造成肌肉无力和乏力,导致运动技能严重损伤. 关键词: 人免疫球蛋白;静脉注射液;FDA批准;慢性炎症性脱髓鞘性多发...
It is not known whether Gamunex-C can cause fetal harm when administered to a pregnant woman. Therefore, Gamunex-C should be given to a pregnant woman only if clearly needed. The use of Gamunex-C has not been evaluated in nursing mothers. ...
FDA批准Talecris Biotherapeutics公司Gamunex-C[免疫球蛋白注射液(人用),10%辛酸酯/色谱纯化]用于皮下注射,治疗原发性免疫缺陷(primary immunodeficiency,PI)。皮下给药途径的获批是对已经获批的用于治疗PI和其他两种适应症(慢性炎性脱髓鞘性多神经病和特发性血小板减少性紫癜)的静脉给药途径的补充。 关键词: 原发性...
GAMUNEX®-C (immune globulin injection [human], 10% caprylate/chromatography purified) is indicated for the treatment of primary humoral immunodeficiency disease (PIDD) in patients 2 years of age and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory ...